Hormone dynamics, pharmacokinetics, safety and efficacy of leuprorelin acetate 6-month depot formulation and tamoxifen adjuvant endocrine therapy combination in premenopausal patients with hormone receptor-positive breast cancer

被引:0
|
作者
Kurebayashi, J.
Toyama, T.
Sumino, S.
Fujimoto, T.
机构
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[2] Nagoya City Univ Hosp, Nagoya, Aichi, Japan
[3] Takeda Pharmaceut Co Ltd, Osaka, Japan
关键词
D O I
10.1158/1538-7445.SABCS15-P5-12-07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-12-07
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer
    Conte, Benedetta
    Poggio, Francesca
    Del Mastro, Lucia
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1357 - 1362
  • [22] Clinical efficacy of combined goserelin and anastrozole in neoadjuvant endocrine therapy for premenopausal women with hormone receptor-positive breast cancer
    Han, Xu
    Li, Hui
    Zhou, Shui-Ying
    Dong, Sha-Sha
    Zhang, Gang-Ling
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [23] An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer
    Verma, S.
    Sehdev, S.
    Joy, A.
    Madarnas, Y.
    Younus, J.
    Roy, J. A.
    CURRENT ONCOLOGY, 2009, 16 : S3 - S15
  • [24] Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
    Fontein, Duveken B. Y.
    Charehbili, Ayoub
    Nortier, Johan W. R.
    Kranenbarg, Elma Meershoek-Klein
    Kroep, Judith R.
    Putter, H.
    van Riet, Yvonne
    Nieuwenhuijzen, Grard A. P.
    de Valk, Bart
    Terwogt, Jetske M. Meerum
    Algie, Gijs D.
    Liefers, Gerrit-Jan
    Linn, Sabine
    van de Velde, Cornelis J. H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) : 2190 - 2200
  • [25] Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China
    Zhong, Xiaorong
    Chen, Ping
    He, Ping
    Wu, Yanqi
    Suo, Jiaojiao
    Zhu, Kunrui
    Yan, Xi
    Tian, Tinglun
    Yang, Qing
    Luo, Ting
    CLINICAL BREAST CANCER, 2024, 24 (02) : e41 - e50
  • [26] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [27] Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
    Nardin, Simone
    Ruelle, Tommaso
    Giannubilo, Irene
    Del Mastro, Lucia
    TUMORI JOURNAL, 2024, 110 (03): : 162 - 167
  • [28] Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients
    Crystal, Jessica S.
    Rand, Jamie
    Johnson, Jeffrey
    Kim, Sungjin
    Basho, Reva
    Amersi, Farin
    Giuliano, Armando E.
    Chung, Alice
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 63 - 74
  • [29] Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients
    Jessica S. Crystal
    Jamie Rand
    Jeffrey Johnson
    Sungjin Kim
    Reva Basho
    Farin Amersi
    Armando E. Giuliano
    Alice Chung
    Breast Cancer Research and Treatment, 2020, 184 : 63 - 74
  • [30] Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor-positive breast cancer
    Lin, Jinna
    Ouyang, Yiye
    Li, Yudong
    Jin, Liang
    Li, Shunying
    Liu, Yujie
    Yang, Yaping
    Shi, Qianfeng
    Zhu, Mengdi
    Cai, Zijie
    Wang, Jingru
    Liu, Nianqiu
    Hu, Yue
    Wu, Zongqi
    Wu, Mengzi
    Wong, Lok Lam
    Jiang, Xiaoting
    Wang, Qi
    Yang, Wang
    Liu, Qiang
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (10): : 1587 - 1597